Table 2

Concentration required to provoke a 15% decrease in FEV0.5 (PC15FEV0.5), the corresponding response in LFOT parameters, and the magnitude of the response in SD units

Patient no PC15FEV0.5 Raw Iaw G H η
1 (H)1Br
2 (D)112.61 (3.3)–3.88 (–0.3)–3.66 (–0.5)6.07 (0.3)–8.85 (–0.3)
3 (D)156.82 (7.8)95.76 (113.1)18.03 (4.4)–19.95 (–2.5)46.31 (8.5)
4 (H)16Br
5 (D)0.544.53 (4.6)48.95 (6.9)20.86 (1.5)9.77 (3.3)6.54 (0.4)
6 (D)4Br
7 (D)1Br
8 (H)0.2576.09 (41.5)164.47 (22.3)62.57 (2.5)–17.17 (–3.8)13.96 (2.6)
9 (D)AwAw
10 (H)16Br
11 (H)AwAw
12 (D)AwAw
13 (D)2Br
14 (H)1682.67 (9.7)45.35 (11.1)149.03 (4.7)–9.97 (–2.1)166.11 (4.6)
15 (D)4Br
16 (H)294.96 (24.5)221.96 (53.6)30.83 (1.6)–7.66 (–1.2)41.54 (1.7)
17 (D)1Br
Mean (SE)4.7(1.7)61.28 (12.22) (15.2 (6.1))95.43 (34.31) (34.4 (17.5))46.28 (22.36) (2.4 (0.8))–6.48 (4.94)
(–1.0 (1.0))
44.26 (25.83) (2.9 (1.3))
  • PC15FEV0.5 is expressed in mg/ml; oscillatory mechanical parameters are shown as percentage increase from control with the magnitude of the response expressed in SD units (shown in parentheses).

  • Raw = airway resistance; Iaw = airway inertance; G = tissue damping; H = tissue elastance; η = tissue hysteresivity; Aw = infant awoke before completion of test; Br = pause in breathing of sufficient length to introduce the low frequency oscillation could not be induced; (H) = healthy; (D) = diseased.